SAN FRANCISCO – Caliper® Life Sciences, a Perkin-Elmer Company, launched their new Vectra™ 2 with AQUA technology, an integrated solution for quantification of protein biomarkers in tissue, at the Molecular Targets & Cancer Therapeutics meeting here this week. Caliper and HistoRx® collaborated on this new immunofluorescent imaging and analysis solution that will deliver objective, quantitative, […]
ITHACA, N.Y.–Rheonix today announced the appointment of two individuals—Tom Karpen as Vice President of Operations overseeing engineering, production and quality teams and Terry Howell as Quality Manager. These two new members to the management team will be instrumental as the Company moves toward commercialization of its Rheonix CARD® system, a powerful automated microfluidic platform capable […]
SAN DIEGO – Gen-Probe Incorporated announced today that long-time chairman Hank Nordhoff has informed the board that he plans to retire at the end of 2011, and that the board has elected Carl Hull, the Company’s president and chief executive officer (CEO), to succeed him. Mr. Nordhoff led Gen-Probe as president and CEO from 1994 […]
OMAHA, Neb.–Transgenomic, Inc. announced the launch of two innovative genetic tests at the annual meeting of the American Heart Association in Orlando, Florida. The PGxPredict:CLOPIDOGREL Panel is a uniquely comprehensive test to predict a patient’s response to clopidogrel (Plavix®). The company has also expanded its FAMILION family of tests for inherited heart diseases with the […]
CHANTILLY, Va. – Dynex Technologies, Inc., a global manufacturer of products designed to make diagnostic testing easier, more cost-effective, and less labor intensive, will feature its breakthrough Dynex® Agility™ ELISA microplate sample processing system at the MEDICA 2011 – World Forum of Medicine in Dusseldorf, Germany, from November 16 to 19, 2011. The Agility system […]
Abcodia, a specialist company engaged in the validation and discovery of biomarkers of cancer and other age-related diseases and Oxford Gene Technology (OGT) a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, today announced a collaboration aimed at improving the early detection of pancreatic cancer. As part of this collaboration, Abcodia […]
Transgenomic, Inc. (OTC/BB: TBIO) and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic’s SURVEYOR® Scan and WAVE® MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe. “This agreement opens up a broad new channel for SURVEYOR Scan and WAVE MCE targeted to pathologists throughout Europe,” said […]
AUSTIN, Texas–Asuragen, Inc. announced today that data from a multi-center study evaluating its microRNA-based test, miRInform™ Pancreas, for the diagnosis of pancreatic ductal adenocarcinoma (PDAC) in fine needle aspirates, was presented as a Poster of Distinction at the American Pancreatic Association (APA) Annual Meeting being held November 2-5, 2011 in Chicago. Currently, gastroenterologists use endoscopic […]
MUNICH, Nov. – Abbott’s PLEX-ID system provides reliable and rapid results for key microbial biothreat agents and should be considered as a first line analytical tool for biodefense, biosecurity and microbial forensics programs, according to research presented at the 13th Medical Biodefense Conference in Munich. The meeting is a global congress for civilian and military […]
SAN DIEGO and TARRYTOWN, N.Y., Siemens Healthcare Diagnostics (NYSE: SI) and Illumina have entered into a partnership aimed at setting new standards in the use of next-generation sequencing for the rapid, accurate identification of patients’ infectious disease states and potential treatment paths. Through this agreement, the companies plan to make existing Siemens molecular HIV tests […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
